Altrius Capital Management Inc Increases Holdings in The Procter & Gamble Company (NYSE:PG)

Altrius Capital Management Inc raised its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 1.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,127 shares of the company’s stock after purchasing an additional 331 shares during the quarter. Altrius Capital Management Inc’s holdings in Procter & Gamble were worth $3,536,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Wyrmwood Management LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at $29,000. Naples Money Management LLC acquired a new position in Procter & Gamble during the 4th quarter worth $29,000. Criterion Capital Advisors LLC acquired a new position in Procter & Gamble during the 4th quarter worth $33,000. Mendota Financial Group LLC grew its stake in Procter & Gamble by 636.6% during the 4th quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock worth $44,000 after purchasing an additional 261 shares in the last quarter. Finally, Morton Brown Family Wealth LLC grew its stake in Procter & Gamble by 206.6% during the 4th quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company’s stock worth $61,000 after purchasing an additional 281 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE PG traded up $0.37 on Monday, hitting $161.66. 4,620,979 shares of the company’s stock were exchanged, compared to its average volume of 6,928,534. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The firm’s 50-day moving average price is $159.64 and its two-hundred day moving average price is $153.65. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $164.32. The firm has a market cap of $381.54 billion, a price-to-earnings ratio of 26.29, a P/E/G ratio of 3.27 and a beta of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company’s revenue was up .6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 EPS. On average, research analysts expect that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.49%. The ex-dividend date is Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is 65.85%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Barclays boosted their target price on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 23rd. Royal Bank of Canada lifted their price target on Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 24th. Wells Fargo & Company lifted their price target on Procter & Gamble from $162.00 to $170.00 and gave the stock an “overweight” rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. reduced their target price on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a report on Thursday, January 18th. Finally, The Goldman Sachs Group began coverage on Procter & Gamble in a report on Friday, March 1st. They issued a “neutral” rating and a $168.00 target price for the company. Seven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $169.76.

Check Out Our Latest Report on Procter & Gamble

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 3,865 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total transaction of $620,719.00. Following the sale, the insider now owns 11,886 shares in the company, valued at approximately $1,908,891.60. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Procter & Gamble news, insider Susan Street Whaley sold 3,865 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total transaction of $620,719.00. Following the transaction, the insider now owns 11,886 shares of the company’s stock, valued at approximately $1,908,891.60. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Balaji Purushothaman sold 28,369 shares of the stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now directly owns 11,507 shares in the company, valued at approximately $1,858,265.43. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 55,865 shares of company stock worth $9,009,280. 0.17% of the stock is owned by insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.